Format
Sort by

Send to

Choose Destination

Search results

Items: 15

1.

CD34 expression and the outcome of nucleophosmin 1-mutated acute myeloid leukemia.

Juncà J, Garcia O, Garcia-Caro M, Vila J, Zamora L, Cabezón M, Alonso E, de la Banda E, Rodríguez-Hernández I, Ribera JM, Millá F.

Ann Hematol. 2016 Dec;95(12):1949-1954.

PMID:
27595757
2.

Pre-transplant Quantitative Determination of NPM1 Mutation Significantly Predicts Outcome of AIlogeneic Hematopoietic Stem Cell Transplantation in Patients with Normal Karyotype AML in Complete Remission.

Karas M, Steinerova K, Lysak D, Hrabetova M, Jungova A, Sramek J, Jindra P, Polivka J, Holubec L.

Anticancer Res. 2016 Oct;36(10):5487-5498.

PMID:
27798920
3.

Correlation of NPM1 Type A Mutation Burden With Clinical Status and Outcomes in Acute Myeloid Leukemia Patients With Mutated NPM1 Type A.

Jo SY, Park SH, Kim IS, Yi J, Kim HH, Chang CL, Lee EY, Cho YU, Jang S, Park CJ, Chi HS.

Ann Lab Med. 2016 Sep;36(5):399-404. doi: 10.3343/alm.2016.36.5.399.

4.

Mutational analysis of JAK2, CBL, RUNX1, and NPM1 genes in familial aggregation of hematological malignancies.

Hamadou WS, Bourdon V, Gaildrat P, Besbes S, Fabre A, Youssef YB, Regaieg H, Laatiri MA, Eisinger F, Mari V, Gesta P, Dreyfus H, Bonadona V, Dugast C, Zattara H, Faivre L, Jemni SY, Noguchi T, Khélif A, Sobol H, Soua Z.

Ann Hematol. 2016 Jun;95(7):1043-50. doi: 10.1007/s00277-016-2678-y.

PMID:
27106701
5.

Minor BCR-ABL1-Positive Acute Myeloid Leukemia Associated With the NPM1 Mutation and FLT3 Internal Tandem Duplication.

Kim MJ, Ahn S, Jeong SH, Jang JH, Han JH, Choi JR, Cho SR.

Ann Lab Med. 2016 May;36(3):263-5. doi: 10.3343/alm.2016.36.3.263. No abstract available.

6.

Simultaneous detection of mutations and copy number variation of NPM1 in the acute myeloid leukemia using multiplex ligation-dependent probe amplification.

Marcinkowska-Swojak M, Handschuh L, Wojciechowski P, Goralski M, Tomaszewski K, Kazmierczak M, Lewandowski K, Komarnicki M, Blazewicz J, Figlerowicz M, Kozlowski P.

Mutat Res. 2016 Apr;786:14-26. doi: 10.1016/j.mrfmmm.2016.02.001.

PMID:
26894557
7.

Transplant outcomes of the triple-negative NPM1/FLT3-ITD/CEBPA mutation subgroup are equivalent to those of the favourable ELN risk group, but significantly better than the intermediate-I risk group after allogeneic transplant in normal-karyotype AML.

Ahn JS, Kim HJ, Kim YK, Jung SH, Yang DH, Lee JJ, Kim NY, Choi SH, Jung CW, Jang JH, Kim HJ, Moon JH, Sohn SK, Won JH, Kim SH, Kim DD.

Ann Hematol. 2016 Mar;95(4):625-35. doi: 10.1007/s00277-015-2580-z.

PMID:
26692090
8.

The prevalence and clinical profiles of FLT3-ITD, FLT3-TKD, NPM1, C-KIT, DNMT3A, and CEBPA mutations in a cohort of patients with de novo acute myeloid leukemia from southwest China.

Gou H, Zhou J, Ye Y, Hu X, Shang M, Zhang J, Zhao Z, Peng W, Zhou Y, Zhou Y, Song X, Lu X, Ying B.

Tumour Biol. 2016 Jun;37(6):7357-70. doi: 10.1007/s13277-015-4601-x.

PMID:
26676635
9.

Nucleophosmin mutation in de-novo acute myeloid leukemia.

Rastogi P, Naseem S, Varma N, Varma S.

Asia Pac J Clin Oncol. 2016 Mar;12(1):77-85. doi: 10.1111/ajco.12442.

PMID:
26669619
10.

Longitudinal qPCR monitoring of nucleophosmin 1 mutations after allogeneic hematopoietic stem cell transplantation to predict AML relapse.

Xue E, Tresoldi C, Sala E, Crippa A, Mazzi B, Greco R, Messina C, Carrabba MG, Lupo Stanghellini MT, Marktel S, Corti C, Peccatori J, Bernardi M, Ciceri F, Vago L.

Bone Marrow Transplant. 2016 Mar;51(3):466-9. doi: 10.1038/bmt.2015.296. No abstract available.

PMID:
26642331
11.

Selective Toxicity of Investigational Ixazomib for Human Leukemia Cells Expressing Mutant Cytoplasmic NPM1: Role of Reactive Oxygen Species.

Garcia JS, Huang M, Medeiros BC, Mitchell BS.

Clin Cancer Res. 2016 Apr 15;22(8):1978-88. doi: 10.1158/1078-0432.CCR-15-1440.

PMID:
26634271
12.

Deregulation of miR-1, miR486, and let-7a in cytogenetically normal acute myeloid leukemia: association with NPM1 and FLT3 mutation and clinical characteristics.

Seyyedi SS, Soleimani M, Yaghmaie M, Ajami M, Ajami M, Pourbeyranvand S, Alimoghaddam K, Akrami SM.

Tumour Biol. 2016 Apr;37(4):4841-7. doi: 10.1007/s13277-015-4289-y.

PMID:
26526573
13.

Low-Dose Actinomycin-D Induces Redistribution of Wild-Type and Mutated Nucleophosmin Followed by Cell Death in Leukemic Cells.

Brodská B, Holoubek A, Otevřelová P, Kuželová K.

J Cell Biochem. 2016 Jun;117(6):1319-29. doi: 10.1002/jcb.25420.

PMID:
26505272
14.

Immunohistochemical detection of cytoplasmic nucleophosmin in formalin-fixed paraffin-embedded marrow trephine biopsies in acute myeloid leukaemia.

Lit BM, Kwong YL, Wong KF.

J Clin Pathol. 2016 May;69(5):409-14. doi: 10.1136/jclinpath-2015-203175.

PMID:
26500335
15.

Immunohistochemical Detection of NPM1 Mutation in Acute Myeloid Leukemia and its Association With Cup-like Nuclear Morphology of Blasts.

Rastogi P, Naseem S, Varma N, Varma S.

Appl Immunohistochem Mol Morphol. 2016 Apr;24(4):261-7. doi: 10.1097/PAI.0000000000000182.

PMID:
26200838
Items per page

Supplemental Content

Loading ...
Support Center